Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | AZN | AMGN | GILD | BMY |
| Company | Colucid Pharma Cmn | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 46.50 | 160.59 | 408.46 | 131.61 | 64.33 |
| High | 46.55 | 162.72 | 417.36 | 134.32 | 65.25 |
| Low | 46.45 | 160.25 | 406.42 | 131.61 | 64.12 |
| Last | 46.53 | 161.91 | 417.20 | 133.06 | 64.84 |
| Change | +0.03 | +0.49 | +6.26 | -0.15 | +0.12 |
| Percent Change | +0.06% | +0.30% | +1.52% | -0.11% | +0.19% |
| Volume | 127,000 | 3,745,900 | 1,959,700 | 6,833,700 | 9,753,200 |
| 20-Day Average Volume | 245,780 | 3,909,335 | 2,709,270 | 6,990,460 | 12,948,521 |
| Previous | 46.50 | 161.42 | 410.95 | 133.21 | 64.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 166.40 | 381.75 | 132.03 | 62.53 |
| 20-Day Raw Stochastic | 70.00% | 39.30% | 98.14% | 41.92% | 71.20% |
| 20-Day Relative Strength | 67.22 | 40.76 | 71.06 | 52.46 | 62.11 |
| Weighted Alpha | +162.70 | -6.33 | +45.75 | +10.34 | +36.70 |
| Today's Opinion | N/A | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Yesterday's Opinion | N/A | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | N/A | 88% Sell | 72% Buy | 56% Sell | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | +2.49% since 08/03/26 | +10.12% since 08/03/26 | +1.46% since 08/03/26 | -0.96% since 08/03/26 |
| Low | 46.45 on 02/28/17 | 155.32 on 08/04/26 | 376.02 on 08/04/26 | 129.02 on 08/06/26 | 63.20 on 08/06/26 |
| High | 46.55 on 02/28/17 | 164.45 on 08/05/26 | 418.40 on 08/06/26 | 137.80 on 08/05/26 | 66.31 on 08/04/26 |
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | -5.65% since 07/10/26 | +14.81% since 07/10/26 | +2.49% since 07/10/26 | +12.61% since 07/10/26 |
| Low | 46.20 on 01/30/17 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 56.78 on 07/14/26 |
| High | 46.65 on 02/08/17 | 175.04 on 07/29/26 | 418.40 on 08/06/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | -11.45% since 05/08/26 | +25.78% since 05/08/26 | +1.32% since 05/08/26 | +15.46% since 05/08/26 |
| Low | 31.25 on 01/06/17 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 46.65 on 02/08/17 | 196.41 on 07/02/26 | 418.40 on 08/06/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | -16.28% since 02/10/26 | +14.41% since 02/10/26 | -9.62% since 02/10/26 | +6.54% since 02/10/26 |
| Low | 8.65 on 08/29/16 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 46.65 on 02/08/17 | 212.71 on 02/18/26 | 418.40 on 08/06/26 | 157.29 on 02/11/26 | 68.10 on 08/03/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 250,347,552 | 222,170,016 | 165,389,536 | 132,204,520 |
| Shares Outstanding, K | 19,280 | 1,550,908 | 540,632 | 1,241,570 | 2,042,715 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | -30,740,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | N/A | 15,384,000,000 | 8,618,000,000 | 6,960,000,000 | 12,973,000,000 |
| Last Qtr Income, $M | N/A | 2,507,000,000 | 1,819,000,000 | 2,021,000,000 | 3,317,000,000 |
| 60-Month Beta | 1.51 | 0.26 | 0.41 | 0.32 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 03/01/17 | 11/05/26 | 11/03/26 | 10/29/26 | 10/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.59 | 18.10 | 0.00 | 9.85 |